Lead Product(s) : Ketoconazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Novum Pharmaceutical Research Services | ACM Global Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
A Therapeutic Equivalence Study of Ketoconazole Cream 2%
Details : Ketoconazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Tinea Pedis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 18, 2019
Lead Product(s) : Ketoconazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Novum Pharmaceutical Research Services | ACM Global Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ketoconazole
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Zydus Lifesciences Gets USFDA Nod to Market Generic Antifungal Shampoo
Details : Ketoconazole impairs the synthesis of ergosterol, which is a vital component of fungal cell membranes. It is indicated for fungal skin conditions like dandruff.
Product Name : Ketoconazole-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 10, 2025
Lead Product(s) : Ketoconazole
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ketoconazole
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
Details : Nizoral-Generic (ketoconazole) is an antifungal shampoo, which is indicated for the treatment of dandruff & scalp dermatoses.
Product Name : Nizoral-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 26, 2024
Lead Product(s) : Ketoconazole
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ketoconazole
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ketoconazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Tinea Versicolor.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 12, 2024
Lead Product(s) : Ketoconazole
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ketoconazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Novum Pharmaceutical Research Services | ACM Global Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ketoconazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Tinea Pedis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 31, 2019
Lead Product(s) : Ketoconazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Novum Pharmaceutical Research Services | ACM Global Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ketoconazole
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ketoconazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 23, 2014
Lead Product(s) : Ketoconazole
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ketoconazole
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ketoconazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Melanoma.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 10, 2013
Lead Product(s) : Ketoconazole
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ketoconazole
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetic Drug Interaction Study in Healthy Male Subjects
Details : Ketoconazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 01, 2011
Lead Product(s) : Ketoconazole
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ketoconazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ketoconazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Tinea Pedis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 26, 2010
Lead Product(s) : Ketoconazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
